Meloxicam Sandoz (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes the inflammatory response and alleviates pain.

The appropriate dose of Meloxicam Sandoz is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of meloxicam during pregnancy and lactation is not well established. It should only be used if the potential benefits outweigh the risks, and only under direct medical supervision. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To order Meloxicam Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloxicam offers a relatively selective COX‑2 inhibition compared with non‑selective NSAIDs like ibuprofen, which may result in a lower incidence of gastrointestinal side effects. However, it still carries risks of cardiovascular and renal events, similar to other NSAIDs, and should be chosen based on individual patient risk profiles.

Meloxicam Sandoz should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Meloxicam Sandoz is taken orally, usually with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed.

Serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity, renal impairment, and an increased risk of cardiovascular events like heart attack or stroke. Patients should report any unusual symptoms to their clinician promptly.

Meloxicam Sandoz should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, severe heart failure, and in individuals with significant renal or hepatic impairment unless specifically advised by a physician.